Original language | English (US) |
---|---|
Pages (from-to) | 569-578 |
Number of pages | 10 |
Journal | Medical mycology |
Volume | 58 |
Issue number | 5 |
DOIs | |
State | Published - Nov 23 2019 |
Bibliographical note
Funding Information:M.M. reports research support and consulting fees from Astellas and Scynexis L.O.Z. has received research, consulting, and/or speaking funds from the following companies: Pfizer, Astellas, Scynexis, Cidara, Amplyx, F2G, Gilead, Viracor, and RealTime.
Funding Information:
G.R.T. reports research support and serving as a consultant for Am-plyx, Cidara, Scynexis, Mayne, F2G, Pfizer. S.C. reports educational grants from Merck.